Detail Information of Xenobiotics
| General Information of Xenobiotics (ID: XEO00722) | ||||||
|---|---|---|---|---|---|---|
| Xenobiotics Name |
Gardiquimod
|
|||||
| Xenobiotics Type |
Pharmaceutical Agent(s)
|
|||||
| Classification |
Preclinical/Patented Drug
|
|||||
| Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=44592366"></iframe>
|
 |
||||
| 3D MOL | 2D MOL | |||||
| PubChem CID | ||||||
| DME(s) Modulated by This Xenobiotics | ||||||
| DME(s) Inhibited by This Xenobiotics | ||||||
| Cytidine aminohydrolase (CDA) | DME Info | Homo sapiens | [1] | |||
| Cytochrome P450 1B1 (CYP1B1) | DME Info | Homo sapiens | [1] | |||
| DME(s) Induced by This Xenobiotics | ||||||
| Carboxylesterase 1 (CES1) | DME Info | Homo sapiens | [1] | |||
| Prostaglandin G/H synthase 2 (COX-2) | DME Info | Homo sapiens | [1] | |||
| References | ||||||
| 1 | Selective IRAK4 inhibition attenuates disease in murine lupus models and demonstrates steroid sparing activity. J Immunol. 2017 Feb 1;198(3):1308-1319. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.